×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LGVN – longeveron inc. - class a common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LGVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/21
08:41 am
lgvn
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/20
09:00 am
lgvn
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
Medium
Report
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
3/11
09:48 am
lgvn
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease [Yahoo! Finance]
3/11
08:30 am
lgvn
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
Medium
Report
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
3/5
09:25 am
lgvn
Longeveron® to Present at the 37th Annual Roth Conference
Medium
Report
Longeveron® to Present at the 37th Annual Roth Conference
3/3
08:10 am
lgvn
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
High
Report
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/2
07:37 am
lgvn
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long [Yahoo! Finance]
High
Report
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long [Yahoo! Finance]
2/28
06:44 pm
lgvn
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
lgvn
longeveron inc. - class a common stock
BEAT
Report
-7.8%
longeveron inc. - class a common stock
8/14/2024
04:05 pm
lgvn
longeveron inc. - class a common stock
MISS
Report
-5.7%
longeveron inc. - class a common stock
5/14/2024
04:05 pm
lgvn
longeveron inc. - class a common stock
BEAT
Report
-5.1%
longeveron inc. - class a common stock
Date
Time
Symbol
Headline
Impact
3/14
04:02 pm
lgvn
Form 8-K Longeveron Inc. For: Mar 13
Low
Report
Form 8-K Longeveron Inc. For: Mar 13
3/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Mar 04 Filed by: Hare Joshua
Medium
Report
Form 4 Longeveron Inc. For: Mar 04 Filed by: Hare Joshua
2/28
04:15 pm
lgvn
Form 8-K Longeveron Inc. For: Dec 31
High
Report
Form 8-K Longeveron Inc. For: Dec 31
2/28
04:01 pm
lgvn
Form 10-K Longeveron Inc. For: Dec 31
Medium
Report
Form 10-K Longeveron Inc. For: Dec 31
1/30
04:41 pm
lgvn
Form 8-K Longeveron Inc. For: Jan 27
Medium
Report
Form 8-K Longeveron Inc. For: Jan 27
1/6
07:16 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Agafonova Nataliya
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Agafonova Nataliya
1/6
07:15 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Hashad Mohamed Wa'el Ahmed
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Hashad Mohamed Wa'el Ahmed
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: